November 13, 2012 -- MD Stem Cells is pleased to announce the first treatment in the United States of a patient with eye disease using a new injection technique for Bone Marrow Derived Stem Cells( BMSC). Dr Steven Levy, President of MD Stem Cells www.mdstemcells.com , indicated the procedure went smoothly and that they are anticipating a positive response in the next several months.
“We are quite familiar with the use of BMSC in ophthalmology for both retinal and optic nerve diseases and have observed macular degeneration, myopic degeneration, hereditary retinopathies and glaucoma patients experience visual improvements following treatment. Our retinal surgeon has used both subretinal surgery and different injection techniques in the past for the placement of BMSC in ocular disease. We have collaboratively developed a dual injection technique that we believe takes advantage of the recently identified active vascular expulsion mechanism of cell transmigration and are very excited about our ability to deliver the BMSC to the RPE, retina and optic nerve.”
Dr Levy indicated that while this particular patient had suffered from optic nerve disease, the next patients will include AMD or macular degeneration and myopic degeneration.
“We believe strongly that regenerative medicine is an evolving arena and that there will be room for any number of approaches to stem cell use to benefit patients.”
